{
  "resourceType": "CodeSystem",
  "id": "oncology-HER2MethodCS",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n<p><b>BC HER2MethodCS CodeSystem</b></p>\n<p>Value set containing methods of determining HER2 status</p>\n</div>"
  },
  "url": "http://hl7.org/fhir/us/breastcancer/CodeSystem/oncology-HER2MethodCS",
  "identifier": {
    "system": "http://hl7.org/fhir/us/breastcancer",
    "value": "oncology.HER2MethodCS"
  },
  "name": "HER2MethodCS",
  "title": "BC HER2MethodCS CodeSystem",
  "status": "draft",
  "publisher": "The HL7 Cancer Interoperability Group sponsored by Clinical Interoperability Council Work Group (CIC).",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "http://standardhealthrecord.org"
        }
      ]
    }
  ],
  "date": "2018-03-21",
  "description": "Value set containing methods of determining HER2 status",
  "caseSensitive": true,
  "content": "complete",
  "count": 3,
  "concept": [
    {
      "code": "single",
      "definition": "HER2 by Single Probe Assay In SituHybridization test",
      "display": "HER2 by Single Probe Assay In SituHybridization test"
    },
    {
      "code": "dual",
      "definition": "HER2 by Dual Probe Assay In SituHybridization test",
      "display": "HER2 by Dual Probe Assay In SituHybridization test"
    },
    {
      "code": "ihc",
      "definition": "HER2 by ImmunoHistochemistry",
      "display": "HER2 by ImmunoHistochemistry"
    }
  ]
}